Search research articles
Contact Us
Filters
Showing results (11-20 of 21) with videos related to
Page
of 3
Sort By:
Archives of Physical Medicine and Rehabilitation
|
October 1, 1989
The benefit of head rotation on pharyngoesophageal dysphagia
J A Logemann, P J Kahrilas, M Kobara, et al.
The American Journal of Gastroenterology
|
June 1, 1989
Absence of an upper esophageal sphincter response to acid reflux
N B Vakil, P J Kahrilas, W J Dodds, et al.
Drug Safety
|
August 2, 2001
Safety and efficacy of long term esomeprazole therapy in patients with healed erosive oesophagitis
P N Maton, N B Vakil, J G Levine, et al.
Journal of Postgraduate Medicine
|
April 1, 1982
Splenic and orbital hydatid cysts and treatment with mebendazole (a case report)
M B Agarwal, M S Kamdar, G H Tilve, et al.
Alimentary Pharmacology & Therapeutics
|
June 26, 2001
The new proton pump inhibitor esomeprazole is effective as a maintenance therapy in GERD patients with healed erosive oesophagitis: a 6-month, randomized, double-blind, placebo-controlled study of efficacy and safety
N B Vakil, R Shaker, D A Johnson, et al.
Gut
|
August 5, 2008
Diagnostic utility of alarm features for colorectal cancer: systematic review and meta-analysis
A C Ford, S J O Veldhuyzen van Zanten, C C Rodgers, et al.
Infection and Immunity
|
April 1, 1997
Localization of Helicobacter pylori urease and heat shock protein in human gastric biopsies
B E Dunn, N B Vakil, B G Schneider, et al.
Journal of Bacteriology
|
August 10, 1999
Identification of a novel penicillin-binding protein from Helicobacter pylori
P Krishnamurthy, M H Parlow, J Schneider, et al.
The American Journal of Gastroenterology
|
February 24, 2001
Esomeprazole once daily for 6 months is effective therapy for maintaining healed erosive esophagitis and for controlling gastroesophageal reflux disease symptoms: a randomized, double-blind, placebo-controlled study of efficacy and safety
D A Johnson, S B Benjamin, N B Vakil, et al.
Infection and Immunity
|
October 24, 1998
Helicobacter pylori containing only cytoplasmic urease is susceptible to acid
P Krishnamurthy, M Parlow, J B Zitzer, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 21) with videos related to
Sort By:
Page
of 3
Archives of Physical Medicine and Rehabilitation
|
October 1, 1989
The benefit of head rotation on pharyngoesophageal dysphagia
J A Logemann, P J Kahrilas, M Kobara, et al.
The American Journal of Gastroenterology
|
June 1, 1989
Absence of an upper esophageal sphincter response to acid reflux
N B Vakil, P J Kahrilas, W J Dodds, et al.
Drug Safety
|
August 2, 2001
Safety and efficacy of long term esomeprazole therapy in patients with healed erosive oesophagitis
P N Maton, N B Vakil, J G Levine, et al.
Journal of Postgraduate Medicine
|
April 1, 1982
Splenic and orbital hydatid cysts and treatment with mebendazole (a case report)
M B Agarwal, M S Kamdar, G H Tilve, et al.
Alimentary Pharmacology & Therapeutics
|
June 26, 2001
The new proton pump inhibitor esomeprazole is effective as a maintenance therapy in GERD patients with healed erosive oesophagitis: a 6-month, randomized, double-blind, placebo-controlled study of efficacy and safety
N B Vakil, R Shaker, D A Johnson, et al.
Gut
|
August 5, 2008
Diagnostic utility of alarm features for colorectal cancer: systematic review and meta-analysis
A C Ford, S J O Veldhuyzen van Zanten, C C Rodgers, et al.
Infection and Immunity
|
April 1, 1997
Localization of Helicobacter pylori urease and heat shock protein in human gastric biopsies
B E Dunn, N B Vakil, B G Schneider, et al.
Journal of Bacteriology
|
August 10, 1999
Identification of a novel penicillin-binding protein from Helicobacter pylori
P Krishnamurthy, M H Parlow, J Schneider, et al.
The American Journal of Gastroenterology
|
February 24, 2001
Esomeprazole once daily for 6 months is effective therapy for maintaining healed erosive esophagitis and for controlling gastroesophageal reflux disease symptoms: a randomized, double-blind, placebo-controlled study of efficacy and safety
D A Johnson, S B Benjamin, N B Vakil, et al.
Infection and Immunity
|
October 24, 1998
Helicobacter pylori containing only cytoplasmic urease is susceptible to acid
P Krishnamurthy, M Parlow, J B Zitzer, et al.
Page
of 3